Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor Growth

Taro Hitosugi, Lu Zhou, Shannon Elf, Jun Fan, Hee Bum Kang, Jae Ho Seo, Changliang Shan, Qing Dai, Liang Zhang, Jianxin Xie, Ting Lei Gu, Peng Jin, Masa Alečković, Gary LeRoy, Yibin Kang, Jessica A. Sudderth, Ralph J. DeBerardinis, Chi Hao Luan, Georgia Z. Chen, Susan Muller & 12 others Dong M. Shin, Taofeek K. Owonikoko, Sagar Lonial, Martha L. Arellano, Hanna J. Khoury, Fadlo R. Khuri, Benjamin H. Lee, Keqiang Ye, Titus J. Boggon, Sumin Kang, Chuan He, Jing Chen

Research output: Contribution to journalArticle

155 Citations (Scopus)

Abstract

It is unclear how cancer cells coordinate glycolysis and biosynthesis to support rapidly growing tumors. We found that the glycolytic enzyme phosphoglycerate mutase 1 (PGAM1), commonly upregulated in human cancers due to loss of TP53, contributes to biosynthesis regulation in part by controlling intracellular levels of its substrate, 3-phosphoglycerate (3-PG), and product, 2-phosphoglycerate (2-PG). 3-PG binds to and inhibits 6-phosphogluconate dehydrogenase in the oxidative pentose phosphate pathway (PPP), while 2-PG activates 3-phosphoglycerate dehydrogenase to provide feedback control of 3-PG levels. Inhibition of PGAM1 by shRNA or a small molecule inhibitor PGMI-004A results in increased 3-PG and decreased 2-PG levels in cancer cells, leading to significantly decreased glycolysis, PPP flux and biosynthesis, as well as attenuated cell proliferation and tumor growth.

Original languageEnglish (US)
Pages (from-to)585-600
Number of pages16
JournalCancer Cell
Volume22
Issue number5
DOIs
StatePublished - Nov 13 2012

Fingerprint

Phosphoglycerate Mutase
Glycolysis
Growth
Pentose Phosphate Pathway
Neoplasms
Phosphoglycerate Dehydrogenase
Phosphogluconate Dehydrogenase
Small Interfering RNA
Cell Proliferation
3-phosphoglycerate
Enzymes
2-phosphoglycerate

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Cite this

Hitosugi, T., Zhou, L., Elf, S., Fan, J., Kang, H. B., Seo, J. H., ... Chen, J. (2012). Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor Growth. Cancer Cell, 22(5), 585-600. https://doi.org/10.1016/j.ccr.2012.09.020

Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor Growth. / Hitosugi, Taro; Zhou, Lu; Elf, Shannon; Fan, Jun; Kang, Hee Bum; Seo, Jae Ho; Shan, Changliang; Dai, Qing; Zhang, Liang; Xie, Jianxin; Gu, Ting Lei; Jin, Peng; Alečković, Masa; LeRoy, Gary; Kang, Yibin; Sudderth, Jessica A.; DeBerardinis, Ralph J.; Luan, Chi Hao; Chen, Georgia Z.; Muller, Susan; Shin, Dong M.; Owonikoko, Taofeek K.; Lonial, Sagar; Arellano, Martha L.; Khoury, Hanna J.; Khuri, Fadlo R.; Lee, Benjamin H.; Ye, Keqiang; Boggon, Titus J.; Kang, Sumin; He, Chuan; Chen, Jing.

In: Cancer Cell, Vol. 22, No. 5, 13.11.2012, p. 585-600.

Research output: Contribution to journalArticle

Hitosugi, T, Zhou, L, Elf, S, Fan, J, Kang, HB, Seo, JH, Shan, C, Dai, Q, Zhang, L, Xie, J, Gu, TL, Jin, P, Alečković, M, LeRoy, G, Kang, Y, Sudderth, JA, DeBerardinis, RJ, Luan, CH, Chen, GZ, Muller, S, Shin, DM, Owonikoko, TK, Lonial, S, Arellano, ML, Khoury, HJ, Khuri, FR, Lee, BH, Ye, K, Boggon, TJ, Kang, S, He, C & Chen, J 2012, 'Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor Growth', Cancer Cell, vol. 22, no. 5, pp. 585-600. https://doi.org/10.1016/j.ccr.2012.09.020
Hitosugi, Taro ; Zhou, Lu ; Elf, Shannon ; Fan, Jun ; Kang, Hee Bum ; Seo, Jae Ho ; Shan, Changliang ; Dai, Qing ; Zhang, Liang ; Xie, Jianxin ; Gu, Ting Lei ; Jin, Peng ; Alečković, Masa ; LeRoy, Gary ; Kang, Yibin ; Sudderth, Jessica A. ; DeBerardinis, Ralph J. ; Luan, Chi Hao ; Chen, Georgia Z. ; Muller, Susan ; Shin, Dong M. ; Owonikoko, Taofeek K. ; Lonial, Sagar ; Arellano, Martha L. ; Khoury, Hanna J. ; Khuri, Fadlo R. ; Lee, Benjamin H. ; Ye, Keqiang ; Boggon, Titus J. ; Kang, Sumin ; He, Chuan ; Chen, Jing. / Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor Growth. In: Cancer Cell. 2012 ; Vol. 22, No. 5. pp. 585-600.
@article{1d7bea82238a488583dfac8810a436db,
title = "Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor Growth",
abstract = "It is unclear how cancer cells coordinate glycolysis and biosynthesis to support rapidly growing tumors. We found that the glycolytic enzyme phosphoglycerate mutase 1 (PGAM1), commonly upregulated in human cancers due to loss of TP53, contributes to biosynthesis regulation in part by controlling intracellular levels of its substrate, 3-phosphoglycerate (3-PG), and product, 2-phosphoglycerate (2-PG). 3-PG binds to and inhibits 6-phosphogluconate dehydrogenase in the oxidative pentose phosphate pathway (PPP), while 2-PG activates 3-phosphoglycerate dehydrogenase to provide feedback control of 3-PG levels. Inhibition of PGAM1 by shRNA or a small molecule inhibitor PGMI-004A results in increased 3-PG and decreased 2-PG levels in cancer cells, leading to significantly decreased glycolysis, PPP flux and biosynthesis, as well as attenuated cell proliferation and tumor growth.",
author = "Taro Hitosugi and Lu Zhou and Shannon Elf and Jun Fan and Kang, {Hee Bum} and Seo, {Jae Ho} and Changliang Shan and Qing Dai and Liang Zhang and Jianxin Xie and Gu, {Ting Lei} and Peng Jin and Masa Alečković and Gary LeRoy and Yibin Kang and Sudderth, {Jessica A.} and DeBerardinis, {Ralph J.} and Luan, {Chi Hao} and Chen, {Georgia Z.} and Susan Muller and Shin, {Dong M.} and Owonikoko, {Taofeek K.} and Sagar Lonial and Arellano, {Martha L.} and Khoury, {Hanna J.} and Khuri, {Fadlo R.} and Lee, {Benjamin H.} and Keqiang Ye and Boggon, {Titus J.} and Sumin Kang and Chuan He and Jing Chen",
year = "2012",
month = "11",
day = "13",
doi = "10.1016/j.ccr.2012.09.020",
language = "English (US)",
volume = "22",
pages = "585--600",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor Growth

AU - Hitosugi, Taro

AU - Zhou, Lu

AU - Elf, Shannon

AU - Fan, Jun

AU - Kang, Hee Bum

AU - Seo, Jae Ho

AU - Shan, Changliang

AU - Dai, Qing

AU - Zhang, Liang

AU - Xie, Jianxin

AU - Gu, Ting Lei

AU - Jin, Peng

AU - Alečković, Masa

AU - LeRoy, Gary

AU - Kang, Yibin

AU - Sudderth, Jessica A.

AU - DeBerardinis, Ralph J.

AU - Luan, Chi Hao

AU - Chen, Georgia Z.

AU - Muller, Susan

AU - Shin, Dong M.

AU - Owonikoko, Taofeek K.

AU - Lonial, Sagar

AU - Arellano, Martha L.

AU - Khoury, Hanna J.

AU - Khuri, Fadlo R.

AU - Lee, Benjamin H.

AU - Ye, Keqiang

AU - Boggon, Titus J.

AU - Kang, Sumin

AU - He, Chuan

AU - Chen, Jing

PY - 2012/11/13

Y1 - 2012/11/13

N2 - It is unclear how cancer cells coordinate glycolysis and biosynthesis to support rapidly growing tumors. We found that the glycolytic enzyme phosphoglycerate mutase 1 (PGAM1), commonly upregulated in human cancers due to loss of TP53, contributes to biosynthesis regulation in part by controlling intracellular levels of its substrate, 3-phosphoglycerate (3-PG), and product, 2-phosphoglycerate (2-PG). 3-PG binds to and inhibits 6-phosphogluconate dehydrogenase in the oxidative pentose phosphate pathway (PPP), while 2-PG activates 3-phosphoglycerate dehydrogenase to provide feedback control of 3-PG levels. Inhibition of PGAM1 by shRNA or a small molecule inhibitor PGMI-004A results in increased 3-PG and decreased 2-PG levels in cancer cells, leading to significantly decreased glycolysis, PPP flux and biosynthesis, as well as attenuated cell proliferation and tumor growth.

AB - It is unclear how cancer cells coordinate glycolysis and biosynthesis to support rapidly growing tumors. We found that the glycolytic enzyme phosphoglycerate mutase 1 (PGAM1), commonly upregulated in human cancers due to loss of TP53, contributes to biosynthesis regulation in part by controlling intracellular levels of its substrate, 3-phosphoglycerate (3-PG), and product, 2-phosphoglycerate (2-PG). 3-PG binds to and inhibits 6-phosphogluconate dehydrogenase in the oxidative pentose phosphate pathway (PPP), while 2-PG activates 3-phosphoglycerate dehydrogenase to provide feedback control of 3-PG levels. Inhibition of PGAM1 by shRNA or a small molecule inhibitor PGMI-004A results in increased 3-PG and decreased 2-PG levels in cancer cells, leading to significantly decreased glycolysis, PPP flux and biosynthesis, as well as attenuated cell proliferation and tumor growth.

UR - http://www.scopus.com/inward/record.url?scp=84869077946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869077946&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2012.09.020

DO - 10.1016/j.ccr.2012.09.020

M3 - Article

VL - 22

SP - 585

EP - 600

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 5

ER -